Urigen Pharmaceuticals announces a presentation on interstitial cystitis/painful bladder syndrome

Download PDF Copy

Editorial Checklist

Reviewed

Urigen Pharmaceuticals, Inc.Oct 28 2009

NewsGuard 100/100 Score

Urigen Pharmaceuticals, Inc. (OTCBB:URGP), focused on the development of treatments for urologic disorders and pain, announces a presentation at its offices on October 30, 2009 at 2PM PST. The slides presented will be posted to its website at www.urigen.com after the close of trading that day.

“Interstitial Cystitis/Painful Bladder Syndrome is an important unmet medical need,” said Urigen CEO William J. Garner, MD. “As part of IC Awareness Week, Urigen would like to do its part to offer a presentation based on the work of its scientific founder, Lowell Parsons, MD.”

Source:

Urigen Pharmaceuticals, Inc.

Posted in: Medical Condition News

Tags: Bladder, Cystitis, Interstitial Cystitis, Overactive Bladder, Pain, Pharmaceuticals, Urology

Comments (0)

Download PDF Copy

Suggested Reading

Urine transcriptomics: A new frontier for non-invasive genitourinary disease detection

Urine transcriptomics: A new frontier for non-invasive genitourinary disease detection

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Antibiotic resistance threatens millions of lives worldwide

Antibiotic resistance threatens millions of lives worldwide

Study shows how a single defective BRCA1 gene accelerates cancer development

Study shows how a single defective BRCA1 gene accelerates cancer development

Obesity crisis in the U.S. expected to worsen by 2050

Obesity crisis in the U.S. expected to worsen by 2050

Combination therapy shows promising results in treating stage 3 melanoma

Combination therapy shows promising results in treating stage 3 melanoma

Study focuses on COPD progression in younger populations

Study focuses on COPD progression in younger populations

Global leaders gather at the NFCR Summit to drive breakthroughs in cancer care

Global leaders gather at the NFCR Summit to drive breakthroughs in cancer care

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Tiny molecule offers hope in reducing opioid side effects